Related Experiment Video
Updated: Jul 5, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
The pro-apoptotic protein Par-4 facilitates vascular contractility by cytoskeletal targeting of ZIPK
Susanne Vetterkind1, Kathleen G Morgan
1Boston Biomedical Research Institute, Watertown, MA, USA.
Abstract:
Par-4 (prostate apoptosis response 4) is a pro-apoptotic protein and tumour suppressor that was originally identified as a gene product up-regulated during apoptosis in prostate cancer cells. Here, we show, for the first time, that Par-4 is expressed and co-localizes with the actin filament bundles in vascular smooth muscle. Furthermore, we demonstrate that targeting of ZIPK to the actin filaments, as observed upon PGF-2alpha stimulation, is inhibited by the presence of a cell permeant Par-4 decoy peptide. The same decoy peptide also significantly inhibits PGF-2alpha induced contractions of smooth muscle tissue. Moreover, knockdown of Par-4 using antisense morpholino nucleotides results in significantly reduced contractility, and myosin light chain and myosin phosphatase target subunit phosphorylation. These results indicate that Par-4 facilitates contraction by targeting ZIPK to the vicinity of its substrates, myosin light chain and MYPT, which are located on the actin filaments. These results identify Par-4 as a novel regulator of myosin light chain phosphorylation in differentiated, contractile vascular smooth muscle.
Insights
Prostate apoptosis response 4 (Par-4) protein regulates vascular smooth muscle contraction. Par-4 targets ZIPK to actin filaments, impacting myosin light chain phosphorylation and smooth muscle contractility.
Area of Science:
- Molecular Biology
- Cell Biology
- Physiology
Background:
- Prostate apoptosis response 4 (Par-4) is a known pro-apoptotic protein and tumor suppressor.
- Par-4 was initially identified for its role in prostate cancer apoptosis.
- Its function in non-cancerous differentiated vascular smooth muscle cells was previously unknown.
Purpose of the Study:
- To investigate the expression and function of Par-4 in vascular smooth muscle.
- To determine Par-4's role in regulating smooth muscle contraction and associated signaling pathways.
Main Methods:
- Immunofluorescence to assess Par-4 localization with actin filaments in vascular smooth muscle.
- Use of a cell-permeant Par-4 decoy peptide to inhibit protein interactions.
- Assessment of smooth muscle tissue contractility.
- Knockdown of Par-4 using antisense morpholino nucleotides.
- Measurement of myosin light chain (MLC) and myosin phosphatase target subunit (MYPT) phosphorylation.
Main Results:
- Par-4 is expressed in vascular smooth muscle and co-localizes with actin filaments.
- A Par-4 decoy peptide inhibited ZIPK targeting to actin filaments and PGF-2alpha-induced smooth muscle contraction.
- Par-4 knockdown reduced contractility and phosphorylation of MLC and MYPT.
Conclusions:
- Par-4 plays a critical role in regulating vascular smooth muscle contraction.
- Par-4 facilitates contraction by targeting ZIPK to its substrates, MLC and MYPT, on actin filaments.
- Par-4 is identified as a novel regulator of myosin light chain phosphorylation in contractile vascular smooth muscle.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
PI3K/mTOR/AKT Signaling Pathway
Cellular Injury V: Apoptosis and Autophagy

